Trending/tolvaptan
Vicente Torres, M.D., Ph.D., discusses new findings on tolvaptan as autosomal dominant polycystic kidney disease treatment
ROCHESTER, Minn. – A phase 3 trial studying the effects of tolvaptan has found that the drug slowed the rate of decline in kidney function…
No information found.
Special Topics
Sign up
Mayo Clinic Connect
An online patient support community